Loading...
We would love for you to become a part of our community. Join our Discord to connect with us and other members!
- Ticker
- ALIMP.PA
- Price
- 0.11
- Stock movement up
- +0.00 (0.46%)
- Company name
- Implanet SA
- Exchange
- (PA ,
- Currency
- EUR )
- Sector
- Healthcare >Medical Devices
- Market cap
- 13.75M
- Ent value
- 22.44M
- Price/Sales
- 1.19
- Price/Book
- 3.93
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -30.36%
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -52.94%
- 1 year return
- 67.94%
- 3 year return
- -29.05%
- 5 year return
- -47.95%
- 10 year return
- -50.65%
Last updated: 2024-12-28
DIVIDENDS
ALIMP.PA does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 1.19 |
| Price to Book | 3.93 |
| EV to Sales | 1.94 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 124.97M |
| EPS (TTM) | -0.08 |
| FCF per share (TTM) | -0.04 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 11.56M |
| Gross profit (TTM) | 5.13M |
| Operating income (TTM) | -8.61M |
| Net income (TTM) | -8.33M |
| EPS (TTM) | -0.08 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 44.32% |
| Operating margin (TTM) | -74.45% |
| Profit margin (TTM) | -72.01% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 1.14M |
| Net receivables | 1.78M |
| Total current assets | 9.31M |
| Goodwill | 1.17M |
| Intangible assets | 1.79M |
| Property, plant and equipment | 0.00 |
| Total assets | 13.33M |
| Accounts payable | 3.80M |
| Short/Current long term debt | 4.59M |
| Total current liabilities | 7.94M |
| Total liabilities | 9.83M |
| Shareholder's equity | 3.50M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -3.82M |
| Capital expenditures (TTM) | 849.00K |
| Free cash flow (TTM) | -4.85M |
| Dividends paid (TTM) | 1.47M |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -237.78% |
| Return on Assets | -62.46% |
| Return on Invested Capital | -126.11% |
| Cash Return on Invested Capital | -73.52% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.12 |
| Daily high | 0.12 |
| Daily low | 0.11 |
| Daily Volume | 36K |
| All-time high | 329.20 |
| 1y analyst estimate | 2.00 |
| Beta | 1.18 |
| EPS (TTM) | -0.08 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ALIMP.PA | S&P500 | |
| Current price drop from All-time high | -99.97% | -2.11% |
| Highest price drop | -99.99% | -56.47% |
| Date of highest drop | 11 Dec 2023 | 9 Mar 2009 |
| Avg drop from high | -85.74% | -11.13% |
| Avg time to new high | 167 days | 12 days |
| Max time to new high | 2773 days | 1805 days |
COMPANY DETAILS
Marketcap
13.75M
Marketcap category
Small-cap
Description
Implanet S.A., a medical technology company, manufactures and sells implants for orthopedic surgery. The company offers spinal and knee products. Its products include Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, Jazz Frame, and ISS-Jazz Screw systems for posterior fixation. The company also provides knee prostheses under the Madison name. The company was founded in 2006 and is based in Martillac, France.
Employees
43
Website
Investor relations
-
SEC filings
CEO
Country
France
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
BORDEAUX, France & BOSTON, December 05, 2024--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company specializing in ...
December 5, 2024
BORDEAUX, France & BOSTON, October 08, 2024--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company specializing in i...
October 8, 2024
NEW YORK & BORDEAUX, France & CAMBRIDGE, England, September 25, 2024--Regulatory News: elliquence LLC, specializing in advanced minimally invasive surgical technologies, and Implanet (Euronext Growth:...
September 25, 2024
BORDEAUX, France & BOSTON, September 19, 2024--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME), a medical technology company specializing in implants for orthope...
September 19, 2024
BORDEAUX, France & BOSTON, September 10, 2024--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME), a medical technology company specializing in implants for orthope...
September 10, 2024
BORDEAUX, France & BOSTON, July 09, 2024--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company specializing in impl...
July 9, 2024
BORDEAUX, France & BOSTON, May 13, 2024--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company specializing in verte...
May 13, 2024
BORDEAUX, France & BOSTON, April 25, 2024--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company specializing in ver...
April 25, 2024
BORDEAUX, France & BOSTON, April 09, 2024--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company specializing in ver...
April 9, 2024
BORDEAUX, France & BOSTON, March 06, 2024--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plan), a medical technology company specialized in impla...
March 6, 2024
Next page